1. Home
  2. STC vs BEAM Comparison

STC vs BEAM Comparison

Compare STC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewart Information Services Corporation

STC

Stewart Information Services Corporation

HOLD

Current Price

$72.72

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.10

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STC
BEAM
Founded
1893
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
STC
BEAM
Price
$72.72
$26.10
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$77.50
$48.09
AVG Volume (30 Days)
250.0K
1.9M
Earning Date
02-04-2026
11-04-2025
Dividend Yield
2.93%
N/A
EPS Growth
69.60
N/A
EPS
3.60
N/A
Revenue
$2,796,513,000.00
$55,701,000.00
Revenue This Year
$17.67
N/A
Revenue Next Year
$10.14
$26.52
P/E Ratio
$19.91
N/A
Revenue Growth
16.09
N/A
52 Week Low
$56.39
$13.53
52 Week High
$78.61
$35.25

Technical Indicators

Market Signals
Indicator
STC
BEAM
Relative Strength Index (RSI) 48.08 53.28
Support Level $71.13 $25.53
Resistance Level $74.91 $27.87
Average True Range (ATR) 2.36 1.67
MACD -0.42 -0.03
Stochastic Oscillator 38.75 49.62

Price Performance

Historical Comparison
STC
BEAM

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: